Remove Barriers To Ensure Launch Success and Accelerate Uptake Clinical Trial Design to Maximize Market Access Pricing Strategies Coding Applications Patient Assistance Planning Coverage Advocacy With Payers Prior to FDA approval and post-launch Representing clients to Medicare and Medicaid, all private insurers, and ICER Since 1998, Pricing and Market Access Support for Hundreds of Drugs and Devices Specializing in drugs that are high cost, clinically complex, combinations with devices/diagnostics, Orphan or 505(b)(2) Focusing on adoption and revision of government and private insurance coverage policies for those products
